AWM
GILD icon

Aberdeen Wealth Management’s Gilead Sciences GILD Stock Holding History

Aberdeen Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
7,240
+1
+0% +$140 0.46% 45
2025
Q4 		$889K Buy
7,239
+1
+0% +$122 0.41% 50
2025
Q3 		$803K Buy
7,238
+3
+0% +$341 0.5% 57
2025
Q2 		$802K Buy
7,235
+4
+0.1% +$426 0.53% 59
2025
Q1 		$810K Buy
7,231
+3
+0% +$310 0.56% 50
2024
Q4 		$668K Sell
7,228
-196
-3% -$17.6K 0.46% 63
2024
Q3 		$622K Sell
7,424
-840
-10% -$64.1K 0.41% 75
2024
Q2 		$567K Buy
8,264
+5
+0.1% +$334 0.38% 75
2024
Q1 		$605K Buy
8,259
+805
+11% +$61.9K 0.35% 75
2023
Q4 		$604K Sell
7,454
-796
-10% -$61.9K 0.44% 69
2023
Q3 		$618K Buy
8,250
+4
+0% +$308 0.47% 60
2023
Q2 		$635K Buy
8,246
+5
+0.1% +$399 0.46% 63
2023
Q1 		$684K Buy
8,241
+4
+0% +$331 0.51% 57
2022
Q4 		$707K Sell
8,237
-196
-2% -$15.5K 0.53% 53
2022
Q3 		$520K Buy
8,433
+3
+0% +$189 0.46% 65
2022
Q2 		$521K Buy
8,430
+329
+4% +$20.4K 0.41% 69
2022
Q1 		$482K Buy
8,101
+164
+2% +$10.5K 0.33% 84
2021
Q4 		$576K Buy
7,937
+153
+2% +$10.5K 0.38% 74
2021
Q3 		$544K Buy
7,784
+223
+3% +$15.7K 0.53% 65
2021
Q2 		$521K Buy
7,561
+3
+0% +$200 0.48% 69
2021
Q1 		$488K Sell
7,558
-183
-2% -$11.8K 0.39% 76
2020
Q4 		$451K Sell
7,741
-95
-1% -$5.73K 0.34% 80
2020
Q3 		$495K Sell
7,836
-852
-10% -$59.1K 0.47% 63
2020
Q2 		$668K Buy
8,688
+857
+11% +$65.7K 0.72% 47
2020
Q1 		$585K Buy
7,831
+168
+2% +$11.6K 0.71% 46
2019
Q4 		$498K Buy
+7,663
New +$499K 0.37% 69

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aberdeen Wealth Management's GILD Position: Q1 2026 in Review

Aberdeen Wealth Management increased its Gilead Sciences (GILD) stake by 0.01% in Q1 2026, buying an estimated $140 and bringing the position to 7,240 shares worth $1.01M. The position accounts for 0.46% of the portfolio, ranked #45.

Aberdeen Wealth Management first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Aberdeen Wealth Management held 7,240 shares of Gilead Sciences worth $1.01M as of Q1 2026.
  • Aberdeen Wealth Management bought 1 Gilead Sciences share in Q1 2026, an estimated $140.
  • Gilead Sciences made up 0.46% of Aberdeen Wealth Management's portfolio in Q1 2026, its #45 holding.
  • Aberdeen Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Aberdeen Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.